← Back to headlines
Biogen Outlines Apellis Deal Financial Impacts
Biogen has detailed the financial impacts of its Apellis deal, projecting a $120M-$130M other income headwind in 2026 and non-GAAP EPS accretion in 2027.
29 Apr, 18:23 — 29 Apr, 18:23
Sources
Showing 1 of 1 sources
